STOCK TITAN

Venus Concept Inc. - VERO STOCK NEWS

Welcome to our dedicated page for Venus Concept news (Ticker: VERO), a resource for investors and traders seeking the latest updates and insights on Venus Concept stock.

Venus Concept Inc. (NASDAQ: VERO) is a pioneering leader in the global medical aesthetic market, offering advanced, minimally invasive, and non-invasive aesthetic and hair restoration technologies. The company stands out with its industry-first subscription model, designed to assist both emerging and established practices in achieving success in the competitive field of aesthetics.

Venus Concept's innovative business model provides aesthetic professionals with unparalleled benefits. These include the most comprehensive warranty program, robust marketing support, continuous clinical education, and valuable practice enhancement programs. This unique approach enables practitioners worldwide to leverage cutting-edge technologies and business solutions to elevate their services and improve the quality of life for their clients.

The company's product portfolio includes a range of advanced aesthetic systems such as Venus Versa™, Venus Legacy™, Venus Velocity™, Venus Viva™, Venus Freeze Plus™, and Venus Skin™. Additionally, Venus Concept provides innovative hair restoration systems like NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. These products address various medical aesthetic needs, including skin rejuvenation, body contouring, hair restoration, and cellulite reduction.

Headquartered in Toronto, Venus Concept operates in over 60 countries and maintains a direct presence in 12 markets, ensuring a global reach and local expertise. The company's latest advancements include the Venus Bliss MAX, a multifunctional platform offering diode laser applicators, Multi-Polar Radio Frequency, and Pulsed Electromagnetic Fields, all designed to treat a variety of aesthetic concerns.

Financially, Venus Concept continues to navigate its growth trajectory with strategic partnerships and investments. The company recently underwent significant debt restructuring, supported by Madryn Asset Management, which aims to enhance its financial stability and compliance with NASDAQ listing requirements. This support underscores a commitment to achieving sustainable profitability and operational efficiency.

Venus Concept's growth is also marked by its continuous expansion into new markets, such as Australia and Israel, where its products like the Venus Versa Pro and Venus Bliss MAX have been well received. These expansions are part of the company's broader strategy to extend its technological innovations to a global clientele, offering practitioners the tools they need to deliver exceptional aesthetic treatments.

Rhea-AI Summary
Venus Concept Inc. (NASDAQ: VERO) announced financial results for the three and nine months ended September 30, 2023. Total revenue was $17.6 million, down 18% year-over-year. Operating expenses decreased by 24%. GAAP net loss was $9.1 million, down 38% year-over-year. The Company established a medical advisory board for AI, received FDA clearance for Venus Versa Pro System, restructured debt, appointed a new President and COO, and launched Venus Aesthetic Intelligence. Revenue guidance for 2023 is $80-82 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.66%
Tags
-
Rhea-AI Summary
Venus Concept Inc. announces the commercial launch of its new multi-application platform Venus Versa Pro in the United States. The platform supports 10 different applicators for various aesthetic conditions and incorporates advanced technologies for skin remodeling and resurfacing. The launch reflects the company's commitment to delivering innovative solutions and introduces the Venus Aesthetic Intelligence rebrand. Venus Versa Pro is expected to contribute to revenue growth in 2024 and beyond.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.08%
Tags
none
-
Rhea-AI Summary
Venus Concept announces company-wide rebranding initiative to reflect a new strategic vision and enhanced focus on emerging technologies in aesthetics.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.04%
Tags
AI
Rhea-AI Summary
Venus Concept promotes Dr. Hemanth Varghese to President and COO, and hires Kirk Gunhus as VP and GM of International Sales and Marketing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.74%
Tags
management
-
Rhea-AI Summary
Venus Concept Inc. to release Q3 financial results on November 14, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.58%
Tags
-
Rhea-AI Summary
Venus Concept announces debt restructuring to improve financial position and support turnaround efforts
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.99%
Tags
Rhea-AI Summary
Venus Concept receives FDA clearance for Venus Versa Pro System, expects revenue growth in 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.78%
Tags
none
-
Rhea-AI Summary
Venus Concept Inc. to participate in H.C. Wainwright 25th Annual Global Investment Conference.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.04%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.32%
Tags
Rhea-AI Summary

Venus Concept Inc. (NASDAQ: VERO) has announced the establishment of a medical advisory board for AI.ME, its next generation robotic platform for fractional skin resurfacing. The board, comprising six leading physicians, will provide strategic input and clinical recommendations for the technology, which received FDA 510(k) clearance in December 2022.

The advisory board includes renowned dermatologists and plastic surgeons: Dr. Glynis Ablon, Dr. Macrene Alexiades, Dr. Eric Bernstein, Dr. James Chao, Dr. Mitchel Goldman, and Dr. Gilly Munavalli. These experts will play a important role in defining AI.ME's commercialization strategy.

AI.ME is the first and only robotic system cleared by FDA for fractional skin resurfacing. It uses machine vision and AI algorithms to target the skin precisely and predictably. Venus Concept expects to begin clinical engagement with the advisory board members in the coming months, with a commercial launch anticipated in the second half of fiscal year 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.92%
Tags
management AI

FAQ

What is the current stock price of Venus Concept (VERO)?

The current stock price of Venus Concept (VERO) is $0.36 as of December 24, 2024.

What is the market cap of Venus Concept (VERO)?

The market cap of Venus Concept (VERO) is approximately 2.6M.

What is Venus Concept Inc. known for?

Venus Concept Inc. is known for its advanced medical aesthetic devices and its unique subscription model that supports aesthetic practices worldwide.

What products does Venus Concept offer?

Venus Concept offers a range of aesthetic devices such as Venus Versa™, Venus Legacy™, Venus Velocity™, Venus Viva™, NeoGraft®, and the ARTAS iX® Robotic Hair Restoration system.

How does Venus Concept’s subscription model benefit practitioners?

The subscription model provides comprehensive warranties, marketing support, continuous education, and practice enhancement programs to help practitioners succeed.

In how many countries does Venus Concept operate?

Venus Concept operates in over 60 countries and maintains a direct presence in 12 markets.

What recent innovations has Venus Concept introduced?

Recent innovations include the Venus Versa Pro and Venus Bliss MAX, which offer advanced technologies for a variety of aesthetic treatments.

What financial steps has Venus Concept taken recently?

Venus Concept has undergone debt restructuring supported by Madryn Asset Management to enhance financial stability and compliance with NASDAQ requirements.

Where is Venus Concept headquartered?

Venus Concept is headquartered in Toronto, Canada.

What areas do Venus Concept’s devices target?

Venus Concept’s devices target skin rejuvenation, body contouring, cellulite reduction, and hair restoration.

Who are some of Venus Concept’s investors?

Venus Concept is backed by EW Healthcare Partners, HealthQuest Capital, Longitude Capital Management, Aperture Venture Partners, and Masters Special Situations.

How does Venus Concept support its product users?

Venus Concept provides extensive support through warranties, marketing, continuous clinical education, and programs designed to enhance practice operations.

Venus Concept Inc.

Nasdaq:VERO

VERO Rankings

VERO Stock Data

2.61M
6.70M
6.08%
27.03%
19.95%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
TORONTO